Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Potential Antidiabetic Activity of Annona muricata Leaves as Enzyme α-amylase Inhibitor: In Silico Study

VALENSI · Vol. ume No. 1 (2026) · hlm. 132–143

DOI
10.15408/jkv.v12i1.46091
ISSN
2548-3013, 2460-6065
Terbit
2026-06-06
Penerbit
Department of Chemistry, Faculty of Science and Technology Syarif Hidayatullah Jakarta State Islamic University
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-sa/4.0

Abstrak

Diabetes mellitus is a prevalent metabolic disorder requiring effective and safe therapeutic approaches. Natural compounds have gained attention as potential alternatives to synthetic drugs such as acarbose, which may cause adverse effects. This study aimed to evaluate the antidiabetic potential of secondary metabolites from Annona muricata leaves as α-amylase inhibitors using an in-silico approach. Molecular docking (PyRx), molecular dynamics simulation (Desmond, 100 ns), and ADMET prediction were performed to assess binding affinity, stability, and drug-likeness properties. Among the tested compounds, three lead compounds exhibited the strongest binding affinity: coclaurine (-9.25 kcal/mol), (+)(-) Xylopine (-8.94 kcal/mol), and annomuricine (-8.82 kcal/mol) compared to acarbose (-4.95 kcal/mol). Molecular dynamics analysis demonstrated annomuricine was the most stable interaction with key catalytic residues (Asp197, Glu233, and Asp300). Additionally,annomuricine satisfied Lipinski’s Rule of Five and showed favorable pharmacokinetic profiles, although it interacted with CYP enzymes. In conclusion, annomuricine demonstrates strong potential as a natural α-amylase inhibitor and may serve as a promising candidate for antidiabetic drug development. However, further in vitro and in vivo studies are required to validate these findings.

Kata kunci

Jaringan kolaborasi para penulis

24 penulis · 69 tautan kepenulisan bersama · 34 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Bakti Tunas Husada
  • Universitas Perjuangan Tasikmalaya
  • National Nuclear Energy Agency of Indonesia
  • Meteorological, Climatological, And Geophysical Agency
  • Padjadjaran University
  • University of Malaya
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Anindita Tri Kusuma PratitaUniversitas Bakti Tunas Husada3
Tifa NofiantiUniversitas Bakti Tunas Husada3
Fajar SetiawanMeteorological, Climatological, And Geophysical Agency2
Nur RahayuningsihUniversitas Bakti Tunas Husada2
Nur Laili Dwi HidayatiUniversitas Bakti Tunas Husada2
Elsi EryantiUniversitas Bakti Tunas Husada2
Aas NuraisahAfiliasi tidak diketahui2
Gina Septiani AgustienUniversitas Perjuangan Tasikmalaya2
Delis SusilawatiUniversitas Perjuangan Tasikmalaya2
Sedin RenadiUniversitas Bakti Tunas Husada2
Gatut Ari WardaniUniversitas Bakti Tunas Husada2
Ade Dwi SeptianUniversitas Bakti Tunas Husada2
Nur Ihsani PertiwiAfiliasi tidak diketahui2
Lina Rahmawati RizkulohAfiliasi tidak diketahui2
Nur Kusaira Khairul IkramUniversity of Malaya2
Veronika Yulianti SusiloNational Nuclear Energy Agency of Indonesia1
Isti DaruwatiNational Nuclear Energy Agency of Indonesia1
Febby PratamaUniversitas Bakti Tunas Husada1
Tita NofiantiUniversitas Bakti Tunas Husada1
Holis Abdul HolikPadjadjaran University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://journal.uinjkt.ac.id/index.php/valensi/oai, pertama di-harvest 10 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Potential Antidiabetic Activity of Annona muricata Leaves as Enzyme α-amylase Inhibitor: In Silico Study</dc:title>
	<dc:creator xml:lang="en">Handirana, Zahra Putri</dc:creator>
	<dc:creator xml:lang="en">Lestari, Tresna</dc:creator>
	<dc:creator xml:lang="en">Mardianingrum, Richa</dc:creator>
	<dc:creator xml:lang="en">Ruswanto, Ruswanto</dc:creator>
	<dc:subject xml:lang="en">Acarbose</dc:subject>
	<dc:subject xml:lang="en">Annona muricata</dc:subject>
	<dc:subject xml:lang="en">antidiabetic</dc:subject>
	<dc:subject xml:lang="en">α-amylase </dc:subject>
	<dc:description xml:lang="en">Diabetes mellitus is a prevalent metabolic disorder requiring effective and safe therapeutic approaches. Natural compounds have gained attention as potential alternatives to synthetic drugs such as acarbose, which may cause adverse effects. This study aimed to evaluate the antidiabetic potential of secondary metabolites from Annona muricata leaves as α-amylase inhibitors using an in-silico approach. Molecular docking (PyRx), molecular dynamics simulation (Desmond, 100 ns), and ADMET prediction were performed to assess binding affinity, stability, and drug-likeness properties. Among the tested compounds, three lead compounds exhibited the strongest binding affinity: coclaurine (-9.25 kcal/mol), (+)(-) Xylopine (-8.94 kcal/mol), and annomuricine (-8.82 kcal/mol) compared to acarbose (-4.95 kcal/mol). Molecular dynamics analysis demonstrated annomuricine was the most stable interaction with key catalytic residues (Asp197, Glu233, and Asp300). Additionally,annomuricine satisfied Lipinski’s Rule of Five and showed favorable pharmacokinetic profiles, although it interacted with CYP enzymes. In conclusion, annomuricine demonstrates strong potential as a natural α-amylase inhibitor and may serve as a promising candidate for antidiabetic drug development. However, further in vitro and in vivo studies are required to validate these findings.</dc:description>
	<dc:publisher xml:lang="en">Department of Chemistry, Faculty of Science and Technology Syarif Hidayatullah Jakarta State Islamic University</dc:publisher>
	<dc:date>2026-06-06</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.uinjkt.ac.id/index.php/valensi/article/view/46091</dc:identifier>
	<dc:identifier>10.15408/jkv.v12i1.46091</dc:identifier>
	<dc:source xml:lang="en">Jurnal Kimia Valensi; Jurnal Kimia VALENSI,  Volume 12, No. 1, May 2026; 132-143</dc:source>
	<dc:source>2548-3013</dc:source>
	<dc:source>2460-6065</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.uinjkt.ac.id/index.php/valensi/article/view/46091/19277</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2026 Ruswanto Ruswanto, Zahra Putri Handirana, Tresna Lestari, Richa Mardianingrum</dc:rights>
	<dc:rights xml:lang="en">https://creativecommons.org/licenses/by-sa/4.0</dc:rights>
</oai_dc:dc>